Applications of Machine Learning in Pharma: From Drug Design to Clinical Trials

Published in

Appsilon

8 min readAug 1, 2024

Machine Learning is transforming how we design drugs, model diseases, develop treatments, and conduct clinical trials.

We recently collaborated with IIMCB to carry out augmented RNA-Ligand binding prediction with machine learning. Learn more about our work in this blog post.

These advancements are helping researchers and healthcare professionals make smarter decisions, accelerate drug development, and improve patient outcomes. In this article, we will explore how with some real-life examples. Let’s begin.

Improving Drug Design Efforts

Machine learning is transforming the way we design drugs, making the process much faster and cost-effective. By quickly analyzing huge datasets, machine learning helps identify potential drug candidates, cutting down the time and expenses traditionally needed for drug discovery. This means new drugs can hit the market faster, giving companies a competitive edge in the pharmaceutical industry.

Take protein structure prediction, for example. Machine learning systems like RoseTTAFold and DeepMind’s AlphaFold have made incredible progress in this area. These systems use pattern recognition to predict the three-dimensional structure of proteins, providing valuable insights that drive drug development forward.

Let’s look at further examples:

AI for Protein Crystal Detection: AI is transforming the field of protein crystal detection, enabling scientists to identify protein crystals much faster than traditional methods.

Take Appsilon’s AI model for protein crystal detection, for example. Appsilon’s model surpasses existing methods in accuracy, efficiency, reducing computational effort and time. This means we can develop new drugs more quickly and effectively, showcasing the impact of AI on protein crystal detection and pharmaceutical research.

Discover how our latest machine learning breakthrough in protein crystal detection, Crystal Clear Vision, is revolutionizing drug design — watch the full story to explore the future of pharmaceutical research.

Enhancing Molecular Docking for Drug Discovery: Machine learning algorithms excel at predicting the binding affinity between potential drug molecules and their target proteins, allowing researchers to identify promising drug candidates with remarkable efficiency.

A recent example of this is the AI-accelerated protein-ligand docking developed for SARS-CoV-2. This approach significantly sped up the virtual screening process, a method used to search compound databases for promising drug leads. This method is 100 times faster than traditional techniques, without sacrificing detection accuracy. This advancement shows how machine learning can enable quicker identification of potential drug molecules for further testing in biological assays.

Drug Repurposing: Exploring large datasets to find new uses for existing drugs can save a lot of time and resources, making drug development much more efficient.

For instance, Dovetail Biopartners used AI to repurpose existing drugs for new treatments. By analyzing vast amounts of data, including clinical records, drug-response profiles, and transcriptomics, they were able to identify promising drug candidates for different diseases. This approach sped up the drug discovery process significantly, showing how AI can quickly and effectively navigate large datasets, transforming the way we develop new drugs.

AI for Genomics and Predictive Modeling

Machine learning is transforming how we understand complex health conditions. Here’s a look at how it’s transforming genomic analysis and predictive modeling.

Decoding Genomes with ML: Machine learning helps us analyze vast genomic datasets to identify genetic markers linked to diseases, offering deeper insights into disease mechanisms. For example, the IntelliGenes study combined transcriptomic data with demographic and clinical information to identify novel biomarkers and predict diseases, revealing details that traditional methods might miss.

Finding Hidden Patterns with ML: Deep learning can uncover patterns and mutations in genomic data that other methods might overlook, leading to more precise interventions.

‍A study in Molecular Psychiatry used deep learning to analyze whole genome sequencing data from 4,179 individuals, uncovering structural variants linked to mental disorders, showing the potential of ML in diagnosing and understanding these conditions.

Unveil the future of genomics with Appsilon’s Gosling.js in Shiny, transforming genomic data analysis.

Predicting Diseases and Patient Outcomes with ML: Machine learning models can accurately predict diseases and patient outcomes using genetic, clinical, and environmental data.

For example, at Appsilon, we collaborated with Boston Medical Center to build a machine learning POC (proof-of-concept) enabling them cluster patients into groups and gain deeper insights into the underlying characteristics of each group. This approach integrated societal and environmental factors into the healthcare datasets, going beyond traditional clinical data, taking a more holistic approach.

Another example would be this study titled “ Cardiovascular complications in a diabetes prediction model using machine learning: a systematic review,” which highlighted how deep learning techniques can accurately predict cardiovascular disease risk in type 2 diabetes patients, aiding in better patient care strategies.

AI for Drug Development

Machine learning is transforming drug development by analyzing vast datasets to find new drug candidates, optimize formulations, and accurately predict potential drug targets.

This technology speeds up the entire process and allows for more personalized treatments tailored to individual patient needs, leading to more effective healthcare solutions.

Keeping Patients Safe with Drug Toxicity Prediction: Machine learning is a game-changer in drug development, especially when it comes to predicting potential drug toxicities. These models help reduce the risk of adverse effects during clinical trials, which not only protects patients but also speeds up the drug development process.

An example is eToxPred, a tool that uses machine learning to predict the toxicity of molecules from their molecular fingerprints. It employs various algorithms, like the Restricted Boltzmann Machine (RBM), Deep Belief Network (DBN), and Extremely Randomized Trees (ET). By identifying potentially toxic compounds early, eToxPred helps ensure patient safety and streamlines the drug development process.

Ensuring Drug Safety with Deep Learning: Deep learning is revolutionizing drug safety assessment by analyzing complex interactions between drugs and biological systems. Its ability to uncover intricate relationships leads to thorough evaluations of drug safety.

An example is the DeepDILI model, which tests AI’s adaptability in regulatory science by simulating the annual addition of new drugs. This model addresses the challenge of evaluating Drug-Induced Liver Injury (DILI), a common cause of toxicity failures. The DeepDILI model demonstrates how deep learning can provide comprehensive safety evaluations, leading to safer pharmaceuticals.

Analyzing Clinical Trial Outcomes

AI has made huge strides in how we analyze clinical trial outcomes. AI-driven methods have transformed the way we examine and interpret clinical trial results, providing valuable insights into the safety and effectiveness of new medical treatments.

Real-time Monitoring with AI: AI is changing the way we handle clinical trials by enabling real-time monitoring. These AI systems can continuously track trial data, quickly identifying trends and potential issues. This constant watchfulness helps make trials more efficient by allowing for quick adjustments, leading to better and faster results.

For example, a remote clinical trial used AI and digital tech for everything from enrollment to data collection and follow-up. Participants used a six-lead ECG monitor for heart monitoring, and the trial recruited through social media ads with electronic consent. Data was collected via self-administered PCR swabs, vital sign measurements, daily symptom surveys, and uploaded ECGs. This trial demonstrated how AI can run clinical trials remotely and in real-time, showcasing its impressive capabilities.

Precision Insights with Deep Learning: Deep learning is transforming clinical trial analysis by accurately identifying who responds to treatments and who doesn’t. This precision enables personalized interventions and better treatment plans, improving patient outcomes and speeding up new therapy development.

For example, the EXAM (electronic medical record X-ray AI model) study used federated learning to predict future oxygen needs for COVID-19 patients based on data from 20 institutes. With an AUC of over 0.92, it showed how deep learning can tailor treatments and optimize strategies, making care more effective and personalized.

Discover how wearables and AI are transforming musculoskeletal health. Dive into our article to explore the cutting-edge advancements and their impact on well-being.

Integrating Machine Learning in Pharmaceutical Operations

Bringing machine learning into pharmaceutical operations isn’t just about adopting new technology- it’s a strategic move to standout in a crowded marketplace.

These advanced tools align perfectly with the industry’s goal of quickly delivering innovative and safe healthcare solutions. When done right, machine learning can lead to significant cost savings, improved efficiency, and a stronger market position.

Here’s more on how machine learning is making a significant impact in these areas:

Speeding Up Drug Design: Machine learning helps predict protein structures and improves molecular docking, making it faster and cheaper to find viable drug candidates.
Cutting Costs with Drug Repurposing: Machine learning can identify new uses for existing drugs, saving time and resources in the development process.
Boosting Efficiency in Drug Development: By predicting drug toxicity and optimizing clinical trials, machine learning makes drug development safer and more efficient, reducing financial risks and inefficiencies.
Optimizing Clinical Trials: Machine learning helps design and monitor clinical trials in real-time, making them more efficient and successful, which cuts costs and speeds up the process of bringing drugs to market.
Enhancing Personalized Medicine: Machine learning enables personalized treatment strategies through patient stratification and non-invasive assessments, improving patient outcomes and boosting the reputation and financial performance of pharmaceutical companies.
Market Competitiveness: Leveraging machine learning helps pharmaceutical companies stay competitive in a fast-paced market by speeding up and improving their processes.

Summing Up Applications of ML in Pharma

Machine learning is changing the game in drug design, drug development, and clinical trials. These technologies can analyze massive amounts of data, uncover hidden patterns, and predict outcomes, revolutionizing healthcare.

As they continue to evolve, we can expect more breakthroughs in drug discovery and disease treatment, leading to better patient care and overall health outcomes.

Shorten timelines, improve discovery rates, cut costs, and get to the next stage faster. Learn more about our work in AI for drug discovery.

Resources

Originally published at https://www.appsilon.com.